Regulus Therapeutics Inc.
Regulus Therapeutics Present New Pre-clinical Data from Multiple Therapeutic Programs at Keystone Symposium
Published in Hepatitis Weekly, January 25th, 2010
Regulus Therapeutics Inc. announced that new pre-clinical data from multiple therapeutic programs were presented at the "RNA Silencing: Mechanism, Biology and Application" Keystone Symposium held January 14 - 19, 2010 in Keystone, Colorado. Regulus and its collaborators presented data showing microRNA target regulation by anti-miRs, as well as data from therapeutic programs focused on oncology, immune disease and hepatitis C virus (HCV) infection.
"The field of microRNA discovery and therapeutic development is growing exponentially and at a tipping point," said Peter S. Linsley, Ph.D., chief scientific officer of Regulus. "The company's innovative chemistries and unique...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2010-01-25)
More Articles from Hepatitis Weekly
- World Journal of Gastroenterology
A novel and simple formula to predict treatment success in chronic hepatitis C - Chronic Hepatitis C Virus
Research in the area of chronic hepatitis C virus reported from University Medical Center - Dengue Fever
Studies from R.A. Agisjuarez and colleagues provide new data on dengue fever - Flavivirus
Studies from Z. Yin et al further understanding of flavivirus - Hepatitis
Scientists at University of Alabama detail research in hepatitis - Hepatitis C Virus
California State University publishes research in hepatitis C virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
